


NP 2 GO operates from Edmond, Oklahoma, providing hybrid telehealth and in-person consultations for patients seeking peptide therapy, metabolic optimization, and hormone support across ten states including Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, and the District of Columbia. The clinic has built a reputation for accessible pricing structures and flexible appointment formats, allowing patients to choose between virtual consultations and face-to-face visits at the Edmond location based on their preferences and clinical needs. With a 4.9-star rating across 820 Google reviews, NP 2 GO has established consistent patient satisfaction through responsive communication and straightforward treatment protocols.
The clinic's peptide and metabolic therapy menu centers on three primary interventions: NAD+ infusions and supplementation for cellular energy and neurological support, semaglutide for appetite regulation and glycemic control in weight management programs, and tirzepatide as a dual GIP/GLP-1 receptor agonist for patients requiring more robust metabolic intervention. NAD+ protocols at NP 2 GO address mitochondrial function, with applications ranging from cognitive clarity to recovery support, administered through IV infusion or subcutaneous injection depending on patient goals and tolerance. Semaglutide treatment follows evidence-based dosing schedules with regular monitoring of weight trends, side effect profiles, and metabolic markers, while tirzepatide is reserved for patients who meet specific clinical criteria or have demonstrated suboptimal response to single-agonist therapies. The clinic structures these treatments within comprehensive programs that include baseline lab assessment, ongoing dose titration, and nutritional guidance to support sustainable outcomes.
NP 2 GO's clinical team consists of nurse practitioners credentialed to practice across the clinic's multi-state telehealth footprint, with protocols designed to ensure continuity of care whether patients engage virtually or in person. Providers conduct initial consultations that include medical history review, current medication reconciliation, and discussion of realistic treatment timelines based on individual metabolic profiles and health objectives. The hybrid model allows for initial in-person assessments at the Edmond clinic when detailed physical examination or baseline body composition analysis is warranted, followed by virtual follow-ups for patients who prefer remote monitoring. This approach has proven effective for weight management patients who benefit from frequent check-ins without the logistical burden of repeated office visits, as well as for NAD+ therapy patients who require periodic infusion sessions but can manage subcutaneous maintenance doses independently.
Patients beginning treatment at NP 2 GO typically start with a consultation that establishes eligibility for peptide therapies, reviews contraindications, and sets measurable benchmarks for progress tracking. Semaglutide and tirzepatide patients receive instruction on subcutaneous self-administration, injection site rotation, and recognition of gastrointestinal side effects that may require dose adjustment. NAD+ patients are educated on the differences between IV and subcutaneous delivery, with IV sessions conducted at the Edmond clinic and subcutaneous protocols available for home administration after proper training. The clinic provides ongoing access to clinical staff for questions about injection technique, side effect management, and protocol adjustments, with response times that reflect the high patient satisfaction scores evident in the clinic's review profile. Follow-up schedules are individualized based on treatment type, with weight management patients typically connecting every two to four weeks and NAD+ patients following protocols that range from weekly infusions to monthly maintenance depending on therapeutic goals.
NP 2 GO's telehealth infrastructure supports patients across its ten-state service area with HIPAA-compliant video platforms, electronic prescribing to local pharmacies, and coordination with compounding facilities for peptide fulfillment. The clinic's pricing model emphasizes transparency, with consultation fees, medication costs, and any additional services outlined before treatment initiation. For patients in Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, and DC who lack convenient access to specialized peptide clinics, NP 2 GO provides a viable alternative to exclusively in-person practices while maintaining the option for Edmond-area residents to utilize the physical clinic for procedures requiring direct clinical oversight. This dual-access model, combined with the clinic's focus on the three core peptide therapies, positions NP 2 GO as a streamlined option for patients seeking metabolic and cellular optimization without navigating complex multi-specialty wellness centers.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


